Skip to content

Advertisement

BMC Geriatrics

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Impact of caring for persons with Alzheimer’s disease or dementia on caregivers’ health outcomes: findings from a community based survey in Japan

  • Amir Goren1Email author,
  • William Montgomery2,
  • Kristin Kahle-Wrobleski3,
  • Tomomi Nakamura4 and
  • Kaname Ueda5
BMC GeriatricsBMC series – open, inclusive and trusted201616:122

https://doi.org/10.1186/s12877-016-0298-y

Received: 3 February 2016

Accepted: 3 June 2016

Published: 10 June 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
3 Feb 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Jun 2016 Editorially accepted
10 Jun 2016 Article published 10.1186/s12877-016-0298-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Health Outcomes Practice, Kantar Health
(2)
Global Patient Outcomes & Real World Evidence, Eli Lilly Australia
(3)
Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Lilly Corporate Center
(4)
Medical Development Unit, Eli Lilly Japan K.K, 7-1-5, Isogami-dori
(5)
Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K, 7-1-5, Isogami-dori

Advertisement